CL2022001168A1 - Acondicionamiento de la carga con salinidad elevada durante la cromatografía de intercambio catiónico para eliminar impurezas relacionadas del producto - Google Patents

Acondicionamiento de la carga con salinidad elevada durante la cromatografía de intercambio catiónico para eliminar impurezas relacionadas del producto

Info

Publication number
CL2022001168A1
CL2022001168A1 CL2022001168A CL2022001168A CL2022001168A1 CL 2022001168 A1 CL2022001168 A1 CL 2022001168A1 CL 2022001168 A CL2022001168 A CL 2022001168A CL 2022001168 A CL2022001168 A CL 2022001168A CL 2022001168 A1 CL2022001168 A1 CL 2022001168A1
Authority
CL
Chile
Prior art keywords
cation exchange
exchange chromatography
conditioning
product
batch
Prior art date
Application number
CL2022001168A
Other languages
English (en)
Spanish (es)
Inventor
Natalia Gomez
Luis Diaz
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CL2022001168A1 publication Critical patent/CL2022001168A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CL2022001168A 2019-11-07 2022-05-04 Acondicionamiento de la carga con salinidad elevada durante la cromatografía de intercambio catiónico para eliminar impurezas relacionadas del producto CL2022001168A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962931863P 2019-11-07 2019-11-07

Publications (1)

Publication Number Publication Date
CL2022001168A1 true CL2022001168A1 (es) 2023-01-27

Family

ID=73598211

Family Applications (3)

Application Number Title Priority Date Filing Date
CL2022001168A CL2022001168A1 (es) 2019-11-07 2022-05-04 Acondicionamiento de la carga con salinidad elevada durante la cromatografía de intercambio catiónico para eliminar impurezas relacionadas del producto
CL2024001788A CL2024001788A1 (es) 2019-11-07 2024-06-14 Método para purificar una proteína multiespecífica a partir de una composición por cromatografía intercambio catiónico.
CL2025003712A CL2025003712A1 (es) 2019-11-07 2025-11-26 Métodos para purificar composición (anticuerpos biespecificos) altos en nacl en cromatografía intercambio catiónico.

Family Applications After (2)

Application Number Title Priority Date Filing Date
CL2024001788A CL2024001788A1 (es) 2019-11-07 2024-06-14 Método para purificar una proteína multiespecífica a partir de una composición por cromatografía intercambio catiónico.
CL2025003712A CL2025003712A1 (es) 2019-11-07 2025-11-26 Métodos para purificar composición (anticuerpos biespecificos) altos en nacl en cromatografía intercambio catiónico.

Country Status (13)

Country Link
US (1) US20220372070A1 (enExample)
EP (1) EP4055041A1 (enExample)
JP (2) JP7760500B2 (enExample)
KR (1) KR20220092969A (enExample)
CN (1) CN114746441A (enExample)
AU (1) AU2020380256A1 (enExample)
BR (1) BR112022008649A2 (enExample)
CA (1) CA3160143A1 (enExample)
CL (3) CL2022001168A1 (enExample)
IL (1) IL292594A (enExample)
MX (1) MX2022005593A (enExample)
WO (1) WO2021091932A1 (enExample)
ZA (1) ZA202205010B (enExample)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7053500A (en) * 1999-09-15 2001-04-17 Eli Lilly And Company Chymotrypsin-free trypsin
EP2001898A1 (en) 2006-03-20 2008-12-17 Medarex Inc. Protein purification
EP2009101B1 (en) 2006-03-31 2017-10-25 Chugai Seiyaku Kabushiki Kaisha Antibody modification method for purifying bispecific antibody
CN104628846B (zh) * 2013-11-06 2019-12-06 三生国健药业（上海）股份有限公司 重组蛋白质的纯化方法
US9611325B2 (en) 2014-07-21 2017-04-04 Wuhan Yzy Biopharma Co., Ltd. Construction and application of bispecific antibody HER2xCD3
CA2963692A1 (en) * 2014-10-09 2016-04-14 Engmab Ag Bispecific antibodies against cd3epsilon and ror1
JP6699085B2 (ja) * 2015-03-25 2020-05-27 東ソー株式会社 Ｆｃ結合性タンパク質の精製方法
TW202600611A (zh) 2017-11-01 2026-01-01 日商中外製藥股份有限公司 生物活性降低之抗體變異體與同功型
CN110305217B (zh) * 2018-03-27 2022-03-29 广州爱思迈生物医药科技有限公司 双特异性抗体及其应用

Also Published As

Publication number Publication date
CN114746441A (zh) 2022-07-12
MX2022005593A (es) 2022-06-09
JP2026012744A (ja) 2026-01-27
IL292594A (en) 2022-07-01
AU2020380256A1 (en) 2022-06-09
KR20220092969A (ko) 2022-07-04
JP7760500B2 (ja) 2025-10-27
CL2025003712A1 (es) 2026-01-09
JP2022554282A (ja) 2022-12-28
EP4055041A1 (en) 2022-09-14
US20220372070A1 (en) 2022-11-24
CL2024001788A1 (es) 2024-09-27
BR112022008649A2 (pt) 2022-07-19
WO2021091932A1 (en) 2021-05-14
ZA202205010B (en) 2023-01-25
CA3160143A1 (en) 2021-05-14

Similar Documents

Publication Publication Date Title
PH12021553000A1 (en) Multispecific proteins
MX2022011973A (es) Composiciones de proteina anti-vegf y metodos para producir la misma.
EA202092464A1 (ru) Способы получения стабильных композиций на основе белков
EA201890640A1 (ru) Рекомбинантные векторы, содержащие пептид 2а
PH12020550099A1 (en) Fusion protein comprising an fgf-18 moiety
MY194660A (en) Alkoxycarbonylation of trivinylcyclohexane
PL3765433T3 (pl) Sposób wytwarzania glikolu etylenowego
MX2017011189A (es) Dsba y dsbc ultrapurificado y métodos para elaborarlos y utilizarlos.
IL278932A (en) Process for the synthesis of (S)-3-amino-4-(difluoromethylnyl)cyclopent-1-ene-1-carboxylic acid
MX2018000845A (es) Vector vírico orf recombinante.
PL3765432T3 (pl) Sposób wytwarzania glikolu etylenowego
EA201790349A1 (ru) Производные 6-алкинил-пиридина в качестве миметиков белка smac
JOP20220041A1 (ar) عملية صناعية لتحضير إستيرول عالي النقاء
EP3891114A4 (en) METHODS FOR THE PRODUCTION OF HIGH PURITY TRIFLUOROIODOMETHANE
ZA202101433B (en) An improved process for the preparation of recombinant lectin protein
CO2018010286A2 (es) Método para la purificación de proteínas
MX2022005593A (es) Acondicionamiento de la carga con salinidad elevada durante la cromatografia de intercambio cationico para eliminar impurezas relacionadas del producto.
EP3752901A4 (en) IDENTIFYING SUBSTITUTE 3D IMAGES FOR 2D IMAGES VIA CLASSIFICATION CRITERIA
MY207512A (en) Process for manufacturing alkanesulfonic acids
CL2022001169A1 (es) Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto
HUE071489T2 (hu) Eljárás nagy tisztaságú izobutilén elõállítására
MY197949A (en) Process for pd-catalyzed hydroxycarbonylation of diisobutene: acetic acid/diisobutene ratio
IL308329A (en) A process for the production of recombinant proteins
IL319767A (en) Process for producing recombinant proteins
GB202308473D0 (en) Process for the production of recombinant proteins